Steven Boas
Pediatric Pulmonology · Northfield, ILNPI 1144227737
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,450 of the $4,358 with a category attached, or 79.2%. AbbVie accounts for 79.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $3,477 and has fallen 99.4% since, to $20 in 2025. Among pediatric pulmonology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $242.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Philips North America LLC$292
- Vertex$182
- Chiesi USA, Inc.$179
- Monaghan Medical Corporation$150
- Sanofi$61
- plus $44 from 1 others
Across 177 payments — averaging $5772.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- First Wave Biopharma, Inc.$442K
- Vertex$226K
- AbbVie$166K
- Insmed, Inc.$126K
- Krystal Biotech Inc$48K
- GSK$13K
What the payments were for
- Consulting fees$3,45079%
- Food & beverage$68516%
- Education$2235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $3,450 |
| Philips North America LLC | 2 | $292 |
| Vertex | 2 | $182 |
| Chiesi USA, Inc. | 9 | $179 |
| Monaghan Medical Corporation | 1 | $150 |
| Sanofi | 2 | $61 |
| Mylan Specialty L.p. | 1 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,358 in reported general payments places this provider in the 90th percentile of 28 pediatric pulmonology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 74 | $1,969,457 |
| CreonLipase/Protease/Amylase | 25 | $184,689 |
| ZenpepLipase/Protease/Amylase | 12 | $111,675 |
| Azithromycin | 22 | $495 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $292 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| VertexTrikafta | $182 | $1,969,45774 claims |
| AbbVieCreon | $3,450 | $184,68925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 28 pediatric pulmonology providers in Illinois.
Other pediatric pulmonology in Northfield
- Susanna McColleyChgo$66K
- Gabriel AljadeffPark Ridge$6K
- Kevin MaupinChicago$2K
- Michael LightSpringfield$2K
- Janaki PaskaradevanChicago$1K
- Avani ShahChicago$839
- David SpielbergChicago$825
- Ajanta PatelChicago$798
- Kimberly WattsPark Ridge$776
- Nizar KherallahPeoria$600
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.